Engineered.Not estimated.
Two engagements. Different industries. Same underlying architecture. Every figure below is real.
Savings follow structure.Never the reverse.
We don’t target a tax outcome. We build the architecture. Entity, capital, timing, discipline. The numbers follow.
The two engagements below are first-year figures. Structure compounds in year two, year five, and at exit. Neither client came in asking for a savings target. Both came in with a constraint. That’s the only honest place to start.
$6M of R&D capitalthat couldn’t be capitalized in-year.
A healthcare operator with a pharmaceutical R&D subsidiary. Combined profits running approximately $6M annually. The subsidiary needed a matching $6M in capital deployment for its current R&D pipeline. Most of that investment wouldn’t generate current-year deductions. Depreciation would unlock over future years as assets came online.
Without intervention, this year’s profits would tax at a 41.8% effective rate, and the shelter would arrive too late to offset the immediate pressure. The operator would be funding the R&D buildout with high-tax dollars while waiting for deductions they couldn’t yet claim.
We established a C-corp MSO alongside the operating entities. A fair and reasonable compensation study justified a $3M annual management fee, approximately half of annual profits. A management agreement documented the arm’s-length services the MSO would deliver to the operating companies: operational oversight, strategic coordination, compliance infrastructure. Every component was engineered to withstand IRS scrutiny on both sides of the transaction.
The $3M routed through the MSO is now taxed at a 23.5% effective rate instead of 41.8%. Annual savings on that slice: $547,500. After entity taxes, $2,295,000 remains in the MSO. That capital is then lent from the MSO back to the operating business as an intercompany loan, funding R&D reinvestment with dollars that never hit the 41.8% personal rate.
The preserved capital isn’t a one-time win. It’s bridge funding. Working capital that stays deployed in the R&D buildout until future-year depreciation catches up. When the R&D assets come online and generate their own deductions, the operator keeps the optionality to either redeploy that preserved capital into the next build cycle or take it personally as profit. Structure did the work that timing couldn’t yet do.
$20M firm revenue.46.9% effective on every dollar.
A law firm running over $20M in annual revenue as an S-corp. All profit distributing to partners personally, landing at a blended 46.9% effective rate. The majority partner’s personal business income was $15M. At that scale, tax wasn’t a deduction against growth. It was consuming the capital that should have been compounding it.
We executed the Loop in four coordinated moves.
A C-corp MSO was established for the majority partner alongside the firm. A $2M annual management fee flowed through the MSO, taxed at a 32.0% corporate effective rate instead of the 46.9% personal rate. Fair and reasonable compensation study and management agreement built the defensibility layer, as always. Entity-layer savings: $297,600.
A relief valve was structured inside the MSO. The mechanism creates capital access from retained corporate earnings without triggering the dividend tax that would apply to a standard shareholder distribution. The partner can now fund personal investments from MSO-held capital without unwinding the tax arbitrage that preserved it in the first place.
$800,000 was allocated to an agricultural operation in which the partner materially participates. Material participation is the hinge. It classifies the operation as active, not passive, which means the deductions it throws off offset ordinary business income rather than being trapped against passive categories most taxpayers can’t use. The structure produced $3,280,000 in active deductions. A 4.1× multiplier on deployed capital.
Those deductions landed against the partner’s $15M of personal business income, producing $1,407,000 in personal tax savings. Combined with the entity-layer arbitrage, total first-year savings: $1,705,000.
And this is where the architecture stops being a transaction and starts being a loop. The agricultural operation generates current-year distributions while holding exit optionality for the future. The relief valve’s capital access compounds with each annual MSO cycle. Fresh allocations every year generate fresh deductions. The structure pays the partner to keep running it.
Two engagements.Same architecture.
What connects these cases isn’t the industry, the dollar figure, or the deduction mechanism. It’s the framework.
The healthcare operator used one lever with precision. Entity restructuring created a timing bridge. One constraint, one intervention, one compounding outcome.
The law firm partner used all four. Entity opened the MSO. Capital built the relief valve. Timing produced active deductions at scale. Discipline deployed them against the highest-taxed income. Every lever was already named in the Wealth Multiplier Loop. The engagement didn’t require inventing strategies. It required selecting them in the right combination and sequencing them in the right order.
That’s the point. Architecture isn’t a library of tactics. It’s the ability to read a constraint, identify which levers respond to it, pull them in the right order, and keep the structure running so each cycle compounds the last.
Your constraints.Not these numbers.
Both engagements began with a constraint analysis, not a savings target. That’s how every engagement we take starts. If you’re running $1M+ in net profit without a deliberately engineered architecture underneath it, the assessment is the asymmetric move.